Biocon consolidated PAT at Rs 187.1 cr. in Q3FY22
Biocon has reported consolidated financial results for the period ended December 31, 2021
Biocon has reported consolidated financial results for the period ended December 31, 2021
The company is focused on the development of novel treatments for RNA viruses
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
The Summit will also witness participation of Union Minister of Health & Family Welfare and Chemicals & Fertilizers Dr. Mansukh Mandaviya
Laurus Labs Limited has reported consolidated financial results for the period ended September 30, 2021
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
Cipla is a leading global pharma company
The consideration for the medicines in India is valued at Rs 180.48 crore
In India, almost all approved vaccines are packed in FIOLAX glass made by SCHOTT
Subscribe To Our Newsletter & Stay Updated